Phase O
II O
study O
of O
carboplatin O
and O
liposomal O
doxorubicin O
in O
patients O
with O
recurrent O
squamous B
cell I
carcinoma I
of I
the I
cervix I
. O

BACKGROUND O
AND O
OBJECTIVES O
: O
Central B
nervous I
system I
and I
cardiac I
toxicity I
following O
the O
administration O
of O
local O
anesthetics O
is O
a O
recognized O
complication O
of O
regional O
anesthesia O
. O

We O
visualize O
, O
for O
the O
first O
time O
, O
the O
profile O
of O
structural B
deficits I
in I
the I
human I
brain I
associated O
with O
chronic O
methamphetamine O
( O
MA O
) O
abuse O
. O

Wilson B
' I
s I
disease I
is O
an O
autosomal O
recessive O
disorder O
of O
hepatic O
copper O
metabolism O
with O
consequent O
copper O
accumulation O
and O
toxicity B
in O
many O
tissues O
and O
consequent O
hepatic B
, I
neurologic I
and I
psychiatric I
disorders I
. O

Damage B
of I
substantia I
nigra I
pars I
reticulata I
during O
pilocarpine O
- O
induced O
status B
epilepticus I
in O
the O
rat O
: O
immunohistochemical O
study O
of O
neurons O
, O
astrocytes O
and O
serum O
- O
protein O
extravasation O
. O

Bilateral O
haemorrhagic B
infarction I
of I
the I
globus I
pallidus I
after O
cocaine O
and O
alcohol O
intoxication O
. O

Drug B
- I
Induced I
Acute I
Liver I
Injury I
Within O
12 O
Hours O
After O
Fluvastatin O
Therapy O
. O

SUMMARY O
: O
A O
63 O
- O
year O
- O
old O
Caucasian O
man O
with O
renal O
amyloidosis B
undergoing O
peripheral O
blood O
stem O
cell O
collection O
for O
an O
autologous O
stem O
cell O
transplant O
developed O
extensive O
bilateral O
upper B
- I
extremity I
deep I
venous I
thrombosis I
( O
DVT B
) O
and O
pulmonary B
embolism I
secondary O
to O
heparin O
- O
induced O
thrombocytopenia B
. O

Since O
intravascular O
fibrin O
thrombi B
are O
often O
observed O
in O
patients O
with O
fibrinolytic O
disorders O
, O
EACA O
should O
not O
be O
implicated O
in O
the O
pathogenesis O
of O
fibrin O
thrombi B
in O
patients O
with O
disseminated B
intravascular I
coagulation I
or O
other O
" O
consumption B
coagulopathies I
. O
" O
This O
report O
describes O
subtotal O
infarction B
of O
the O
kidney O
due O
to O
thrombosis B
of I
a I
normal I
renal I
artery I
. O

CONCLUSION O
: O
Despite O
theoretical O
concerns O
that O
lidocaine O
may O
enhance O
cocaine O
toxicity B
, O
the O
use O
of O
lidocaine O
in O
patients O
with O
cocaine O
- O
associated O
MI B
was O
not O
associated O
with O
significant O
cardiovascular B
or I
central I
nervous I
system I
toxicity I
. O

Paclitaxel O
( O
Taxol O
; O
Bristol O
- O
Myers O
Squibb O
Company O
, O
Princeton O
, O
NJ O
) O
by O
3 O
- O
hour O
infusion O
was O
combined O
with O
carboplatin O
in O
a O
phase O
I O
/ O
II O
study O
directed O
to O
patients O
with O
non B
- I
small I
cell I
lung I
cancer I
. O

